Beleaguered Mallinckrodt Plc (NYSE: MNK) Surges 85% After Selling BioVectra, Inc. Business to H.I.G. Capital For $250 Million
Mallinckrodt Plc (NYSE: MNK) is a global biopharmaceutical company, which focuses on the research, development, manufacture, marketing, and distribution of ...
